⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HIMS

Hims & Hers Health, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

27.90USD

-0.2700 (-0.96%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.06▲$0.0601
Next quarter$0.12▼$0.1300
Current year$-0.55▼$-0.0801
Next year$0.44▼$0.6710

Recent quarters

Beat in 1 of the last 4

QuarterEstimateActualSurprise
2026-06-30$-0.05$-0.37-0.32 (-640.0%)
2026-03-31$0.03$-0.4-0.43 (-1664.3%)
2025-12-31$0.04$0.08+0.04 (+92.5%)
2025-09-30$0.1$0.06-0.04 (-41.0%)

Wall Street coverage

148 ratings from 21 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Truist SecuritiesMaintainedHold$27 $32Aug 24, 2026
BarclaysMaintainedOverweight$39 $35Aug 21, 2026
CitigroupMaintainedNeutral$35 $33Aug 11, 2026
Deutsche BankMaintainedHold$25 $26Aug 11, 2026
B of A SecuritiesMaintainedNeutral$30 $32Aug 11, 2026
TD CowenMaintainedHold$25 $30Aug 11, 2026
Morgan StanleyMaintainedEqual-Weight$21 $28Aug 11, 2026
NeedhamMaintainedBuy$35 $42Aug 11, 2026
Truist SecuritiesMaintainedHold$23 $27Jul 24, 2026
CitigroupMaintainedNeutral$28 $35Jul 23, 2026
B of A SecuritiesMaintainedNeutral$36 $37Jul 9, 2026
Canaccord GenuityMaintainedBuy$32 $40Jul 1, 2026
B of A SecuritiesMaintainedNeutral$25 $36Jul 1, 2026
BarclaysMaintainedOverweight$29 $39Jun 18, 2026
B of A SecuritiesMaintainedNeutral$28 $25May 26, 2026
Truist SecuritiesMaintainedHold$18 $23May 22, 2026
B of A SecuritiesMaintainedNeutral$30 $28May 19, 2026
B of A SecuritiesMaintainedNeutral$32 $30May 13, 2026
CitigroupMaintainedNeutral$24 $28May 12, 2026
JP MorganMaintainedOverweight$35 $33May 12, 2026
BTIGReiteratedNeutral—May 12, 2026
NeedhamMaintainedBuy$30 $35May 12, 2026
JP MorganInitiatedOverweight$35Apr 24, 2026
B of A SecuritiesMaintainedNeutral$30 $32Apr 24, 2026
B of A SecuritiesMaintainedNeutral$21 $25Apr 16, 2026

Insider transactions

156 filings from 16 insiders · 48 buy / 21 sell over 6m

Officers and directors of HIMS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Boughton SoleilOfficer, Chief Legal OfficerSell3.5k$28.33$98kSep 2, 2026
DUDUM ANDREWChief Executive OfficerGiftindirect463.3k——Aug 25, 2026
OKUPE OLUYEMIChief Financial OfficerExercise4.9k$5.01$25kAug 19, 2026
BOUGHTON SOLEILOfficerSell25.1k$27.55$692kAug 19, 2026
OKUPE OLUYEMIChief Financial OfficerSell4.9k$29.99$148kAug 19, 2026
AUTOR DEBORAH MOfficer and DirectorSell16.8k$27.85$467kAug 18, 2026
OKUPE OLUYEMIChief Financial OfficerExercise81.0k$5.01$47kAug 17, 2026
OKUPE OLUYEMIChief Financial OfficerSell64.8k$27.89$2.21MAug 17, 2026
AUTOR DEBORAH MOfficer and DirectorOther32.9k——Aug 14, 2026
BOUGHTON SOLEILOfficerOther42.3k——Aug 14, 2026
CARROLL PATRICK HARRISONOfficerOther26.2k——Aug 14, 2026
WELLS DAVID BDirectorOther778——Aug 14, 2026
PAYNE CHRISTOPHER DDirectorOther545——Aug 14, 2026
SCHULTZ KAREDirectorOther6.6k——Aug 14, 2026
DUDUM ANDREWChief Executive OfficerOther155.0k——Aug 14, 2026
BECKLUND IRENEOfficerOther13.7k——Aug 14, 2026
CHI MICHAEL YChief Operating OfficerOther86.3k——Aug 14, 2026
ELSHENAWY MOHAMEDChief Technology OfficerOther188.3k——Aug 14, 2026
OKUPE OLUYEMIChief Financial OfficerExercise7.2k$5.01$36kJul 17, 2026
OKUPE OLUYEMIChief Financial OfficerSell7.2k$31.99$229kJul 17, 2026

Analyst Notes

Sign in to write

No analyst notes on HIMS yet.

Analyst Ratings

13 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current211200Hold2.67
1 mo ago211101Hold2.80
2 mo ago211200Hold2.67
3 mo ago211101Hold2.80
Price target$31.23$23.00 – $42.00
+11.9% to target